Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Nonantioxidant Tetramethoxystilbene Abrogates α-Synuclein-Induced Yeast Cell Death but Not That Triggered by the Bax or βA4 Peptide. Local targets link to admitted publications; unresolved targets remain external evidence.
α-Synuclein in Lewy bodies
10.1038/42166 · 1997 · External reference
Mechanisms of alpha-synuclein induced synaptopathy in parkinson’s disease
10.3389/fnins.2018.00080 · 2018 · External reference
The Hsp70/Hsp90 Chaperone machinery in neurodegenerative diseases
10.3389/fnins.2017.00254 · 2017 · External reference
Imaging amyloid deposition in Lewy body diseases
10.1212/01.wnl.0000326146.60732.d6 · 2008 · External reference
Gene dosage and pathogenesis of Parkinson’s disease
10.1016/j.molmed.2005.01.001 · 2005 · External reference
Regulation of -Synuclein Expression: Implications for Parkinson’s Disease
10.1101/sqb.2003.68.409 · 2003 · External reference
Familial Parkinson disease mutations influence α-synuclein assembly
10.1016/j.nbd.2011.05.025 · 2011 · External reference
Amyloid precursor protein processing and Alzheimer’s disease
10.1146/annurev-neuro-061010-113613 · 2011 · External reference
Proteolytic processing of Alzheimer’s β-amyloid precursor protein
10.1111/j.1471-4159.2011.07519.x · 2012 · External reference
Yeast cells provide insight into alpha-synuclein biology and pathobiology
10.1126/science.1090439 · 2003 · External reference
α-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson’s disease
10.1111/j.1567-1364.2006.00135.x · 2006 · External reference
Functional Links Between A Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast
10.1126/science.1213210 · 2011 · External reference
A yeast model for amyloid- aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity
10.1242/dmm.010108 · 2013 · External reference
Application of Yeast to Study the Tau and Amyloid-β Abnormalities of Alzheimer’s Disease
10.3233/jad-122035 · 2013 · External reference
Bax, Bak and beyond - mitochondrial performance in apoptosis
10.1111/febs.14186 · 2018 · External reference
BCL-2 family proteins: changing partners in the dance towards death
10.1038/cdd.2017.186 · 2018 · External reference
BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells
10.1016/j.preteyeres.2017.01.002 · 2017 · External reference
Fighting Bax: towards a Parkinson’s disease therapy
10.1016/s0166-2236(00)01837-3 · 2001 · External reference
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
10.1073/pnas.051633998 · 2001 · External reference
Role of mitochondria and C-terminal membrane anchor of Bcl-2 in Bax induced growth arrest and mortality inSaccharomyces cerevisiae
10.1016/0014-5793(96)00044-0 · 1996 · External reference
The pleiotropic effects of heterologous Bax expression in yeast
10.1016/j.bbamcr.2007.12.013 · 2008 · External reference
A universal cloning method based on yeast homologous recombination that is simple, efficient, and versatile
10.1016/j.mimet.2013.11.013 · 2014 · External reference
A noble pathological role for alpha-synuclein in triggering neurodegeneration of Parkinson’s disease
10.1002/mds.27306 · 2018 · External reference
The small GTPase RAC1/CED-10 is essential in maintaining dopaminergic neuron function and survival against alpha-synuclein-induced toxicity
10.1007/s12035-018-0881-7 · 2018 · External reference
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons
10.1016/j.nbd.2017.12.004 · 2018 · External reference
Targeting α-synuclein for treatment of Parkinson’s disease: mechanistic and therapeutic considerations
10.1016/s1474-4422(15)00006-x · 2015 · External reference
Design of an N-Methylated Peptide Inhibitor of α-Synuclein Aggregation Guided by Solid-State NMR§
10.1021/ja075356q · 2008 · External reference
Inhibiting Aggregation of α-Synuclein with Human Single Chain Antibody Fragments
10.1021/bi036281f · 2004 · External reference
Curcumin Modulates α-Synuclein Aggregation and Toxicity
10.1021/cn3001203 · 2013 · External reference
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
10.1073/pnas.0910723107 · 2010 · External reference
Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, α-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms
10.1074/jbc.m111.308668 · 2012 · External reference
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
10.1016/j.febslet.2011.03.046 · 2011 · External reference
Postharvest accumulation of resveratrol and piceatannol in sugarcane with enhanced antioxidant activity
10.1021/jf4020087 · 2013 · External reference
Rapid identification and isolation of inhibitors of rat lens aldose reductase and antioxidant in Maackia amurensis
10.1155/2017/4941825 · 2017 · External reference
Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3
10.1002/mnfr.201600111 · 2016 · External reference
Piceatannol and other wine stilbenes: A pool of inhibitors against alpha-synuclein aggregation and cytotoxicity
10.3390/nu8060367 · 2016 · External reference
Tetrahydroxystilbene glucoside inhibits α-synuclein aggregation and apoptosis in A53T α-synuclein-transfected cells exposed to MPP+
10.1139/cjpp-2016-0209 · 2017 · External reference
Structure and Dynamics of Micelle-bound Human -Synuclein
10.1074/jbc.m411805200 · 2005 · External reference
A combinatorial NMR and EPR approach for evaluating the structural ensemble of partially folded proteins
10.1021/ja100646t · 2010 · External reference
Structure-based design of functional amyloid materials
10.1021/ja509648u · 2014 · External reference
Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein
10.1038/nsmb.3194 · 2016 · External reference
Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
10.1126/science.1227157 · 2012 · External reference
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
10.1038/nature14547 · 2015 · External reference
Alpha synuclein fibrils contain multiple binding sites for small molecules
10.1021/acschemneuro.8b00177 · 2018 · External reference
Several affinity tags commonly used in chromatographic purification
10.1155/2013/581093 · 2013 · External reference
Melatonin improves survival and respiratory activity of yeast cells challenged by alpha-synuclein and menadione
10.1002/yea.3296 · 2018 · External reference
High expression levels of the D686N Parkinson’s disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast
10.3892/mmr.2017.6551 · 2017 · External reference
Nicotine slows down oligomerisation of α-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson’s disease
10.1016/j.bbadis.2017.02.002 · 2017 · External reference
Comparison of methods used for assessing the viability and vitality of yeast cells
10.1111/1567-1364.12202 · 2014 · External reference
A high-throughput assay for mitochondrial membrane potential in permeabilized yeast cells
10.1006/abio.2001.5139 · 2001 · External reference
Oxidative stress and programmed cell death in yeast
10.3389/fonc.2012.00064 · 2012 · External reference
Reactive oxygen species and yeast apoptosis
10.1016/j.bbamcr.2008.01.023 · 2008 · External reference
Quinazoline derivatives as selective CYP1B1 inhibitors
10.1016/j.ejmech.2017.02.032 · 2017 · External reference
A53T in a parkinsonian family: a clinical update of the SNCA phenotypes
10.1007/s00702-016-1578-6 · 2016 · External reference
Relationships between the Sequence of α-Synuclein and its Membrane Affinity, Fibrillization Propensity, and Yeast Toxicity
10.1016/j.jmb.2006.12.044 · 2007 · External reference
Analysis of livingS. cerevisiae cell states-A three color approach
10.1002/cyto.a.20212 · 2006 · External reference
Relation between mitochondrial membrane potential and ROS formation
10.1007/978-1-61779-382-0_12 · 2012 · External reference
The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update
10.1023/a:1022945107762 · 2003 · External reference
Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson’s disease
10.1007/s00709-015-0930-2 · 2017 · External reference
The benefits of humanized yeast models to study Parkinson’s disease
10.1155/2013/760629 · 2013 · External reference
From the baker to the bedside: yeast models of Parkinson’s disease
10.15698/mic2015.08.219 · 2015 · External reference
Yeast unfolds the road map toward α-synuclein-induced cell death
10.1038/cdd.2009.203 · 2010 · External reference
Genesis and development of DPPH method of antioxidant assay
10.1007/s13197-011-0251-1 · 2011 · External reference
Antioxidant activity applying an improved ABTS radical cation decolorization assay
10.1016/s0891-5849(98)00315-3 · 1999 · External reference
Yeast as a Model for Studies on Aβ Aggregation Toxicity in Alzheimer’s Disease, Autophagic Responses, and Drug Screening
10.1007/978-1-4939-2627-5_12 · 2016 · External reference
The secreted form of invertase in Saccharomyces cerevisiae is synthesized from mRNA encoding a signal sequence
10.1128/mcb.3.3.439 · 1983 · External reference
Many random sequences functionally replace the secretion signal sequence of yeast invertase
10.1126/science.3541205 · 1987 · External reference
Natural compounds may open new routes to treatment of amyloid diseases
10.1007/s13311-013-0192-7 · 2013 · External reference
Synthesis of 2-phenylnaphthalenes from styryl-2-methoxybenzenes
10.1039/c4cc05151c · 2014 · External reference
Photoinduced oxidative activation of electron-rich arenes: alkenylation with H2 evolution under external oxidant-free conditions
10.1039/c7sc04634k · 2018 · External reference
Unresolved reference
External reference
A yeast-based model of α-synucleinopathy identifies compounds with therapeutic potential
10.1016/j.bbadis.2005.11.009 · 2006 · External reference
